| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ASCO 2023: new treatment options in CNS tumors
|
Pichler, Josef
|
|
|
16 |
4 |
p. 222-224
|
article
|
| 2 |
ASCO 2023—partnering with patients: the cornerstone of cancer care and research
|
Rinnerthaler, Gabriel
|
|
|
16 |
4 |
p. 215-216
|
article
|
| 3 |
ASCO update—hepatocellular carcinoma and cholangiocellular carcinoma
|
Djanani, Angela
|
|
|
16 |
4 |
p. 234-236
|
article
|
| 4 |
Challenges in prevention, early detection, and management of febrile neutropenia in adult patients with solid tumors
|
Popov, Petar
|
|
|
16 |
4 |
p. 255-258
|
article
|
| 5 |
Comment to Smith MR, Hussain M, Saad F et al. (2022, N Engl J Med) Darolutamide and survival in metastatic, hormone-sensitive prostate cancer
|
Heidegger, Isabel
|
|
|
16 |
4 |
p. 246
|
article
|
| 6 |
Editorial
|
Wöll, Ewald
|
|
|
16 |
4 |
p. 213-214
|
article
|
| 7 |
Erythropoiesis-stimulating agents—benefits and harms in the treatment of anemia in cancer patients
|
Heregger, Ronald
|
|
|
16 |
4 |
p. 259-262
|
article
|
| 8 |
Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer
|
Reimann, Patrick
|
|
|
16 |
4 |
p. 225-229
|
article
|
| 9 |
Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction
|
Roider-Schur, Sophie
|
|
|
16 |
4 |
p. 242-245
|
article
|
| 10 |
Focal therapy in intermediate- and high-risk prostate cancer
|
Huebner, Nicolai A.
|
|
|
16 |
4 |
p. 247-250
|
article
|
| 11 |
HER2 in focus—gastric cancer
|
Ilhan-Mutlu, Aysegül
|
|
|
16 |
4 |
p. 217
|
article
|
| 12 |
Imaging and therapy targeting PSMA receptors for enhanced vision and precise treatment
|
Rasul, Sazan
|
|
|
16 |
4 |
p. 251-254
|
article
|
| 13 |
Management of malignant hypercalcemia in cancer patients—a short review
|
Petrasch, Clemens
|
|
|
16 |
4 |
p. 263-267
|
article
|
| 14 |
Prostate cancer special—part 1
|
Shariat, Shahrokh F.
|
|
|
16 |
4 |
p. 218-219
|
article
|
| 15 |
Renal cell carcinoma
|
Spiegelberg, Jasmin
|
|
|
16 |
4 |
p. 230-233
|
article
|
| 16 |
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma
|
Ilhan-Mutlu, Aysegül
|
|
|
16 |
4 |
p. 237-241
|
article
|
| 17 |
Supportive management
|
Minichsdorfer, PhD, Christoph
|
|
|
16 |
4 |
p. 220-221
|
article
|
| 18 |
WNT3 and LEF1 as markers for diagnosis and survival prediction in chronic lymphocytic leukemia patients
|
Atef, Manal
|
|
|
16 |
4 |
p. 268-274
|
article
|
Journal description